维普期刊资源整合服务平台（V6.5）

30篇 您的检索式：作者名="Bronte G"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	The role of tar- geted therapy for gastrointestinal tumors显示文摘	Rolfo C Bronte G Sortino G	2014	Expert Rev Gastroenterol Hepatol2014，8，8：	1
2	The molecular changes driving the carcinogenesis in Barrettg esophagus: Which came first, the chicken or the egg显示文摘	Russo A Bronte G Cabibi D	2013	Crit Rev Oncol Hemat2013，86，3：	1
3	Fusion of Optimized Indicators from Advanced Driver Assistance Systems (ADAS) for Driver Drowsiness Detection 显示文摘	Ivan G Daza Luis M Bergasa Sebastian Bronte	2014	Sensors2014，14，1：	1
4	The long and winding road touseful predictive factors for anti -EGFR therapy in metastatic col-orectal carcinoma: the KRAS/BRAF pathway显示文摘	Russo A Rizzo S Bronte G	2009	Oncology2009，77，1：	1
5	EGFR genomic alterations incancer:prognostic and predictive values显示文摘	Bronte G Terrasi M Rizzo S	2011	Front Biosci(EliteEd)2011，3，：	1
6	Fusion of Optimized Indicators from Advanced Driver Assistance Systems (ADAS) for Driver Drowsiness Detection 显示文摘	DAZA I G BERGASA L M BRONTE S	2014	Sensors2014，14，1：	1
7	EGFR genomic alterations in cancer : prognostic and predictive values 显示文摘	Bronte G Terrasi M Rizzo S	2011	Front Biosci ( Elite Ed)2011，3，：	1
8	The role of targeted therapy for gas-trointestinal tumors显示文摘	Rolfo C Bronte G Sortino G	2014	Expert Rev Gastroenterol Hepatol2014，8，8：	1
9	Driver mutations and dif- ferential sensitivity to targeted therapies: a new approach to the treatment of lung adenoearcinoma显示文摘	Bronte G Rizzo S La Paglia L	2010	Cancer Treat Rev2010，36，3：	1
10	Prognostic vs predictive molecular biomarkers in colorectal cancer:is KRAS and BRAF wild type status required for anti-EGFR therapy显示文摘	Rizzo S Bronte G Fanale D	2010	Cancer Treat Rev2010，36，3：	1
11	Boosting antitumor responses of T lymphoeytes infiltrating human prostate cancers 显示文摘	Bronte V Kasic T Gri G	2005	J Exp Med2005，201，8：	1
12	A column generation algorithm for choice-based network revenue management 显示文摘	Bront J J M Mendez - Diaz I Vulcano G	2009	Operations Research2009，57，3：	1
13	EGFR genomic alterations in cancer: prognostic and predictive values显示文摘	Bronte G Terrasi M Rizzo S		Front Biosci (Elite Ed)0，6，3：	1
14	Boosting antitumorresponses of T lymphocytes infiltrating human prostatecancers显示文摘	Bronte V Kasic T Gri G	2005	J Exp Med2005，201，：	1
15	Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers显示文摘	Bronte V Kasic T Gri G	2005	J Exp Med2005，201，8：	1
16	BIBF 1120/nintedanib:a new triple angiokinase inhibitor-directed therapy in patients with non-small cell lung cancer显示文摘	Rolfo C Raez LE Bronte G	2013	Expert Opin Investig Drugs2013，22，8：	1
17	The molecular changes driving the carcinogenesis in Barrett's esophagus: which came first, the chicken or the egg? 显示文摘	Russo A Bronte G Cabibi D	2013	Crit Rev Oncol Hematol2013，86，3：	1
18	Driver mutations and differen-tial sensitivity to targeted therapies:a new approach to the treat-ment of lung adenocarcinoma显示文摘	Bronte G Rizzo S La Paglia L		0，，3：	1
19	Monoc\|ona\| antibodies ingastrointesti- nal cancers 显示文摘	Bronte G Cicero G Cusenza S eta\|	2013	Expert Opin Biol Ther2013，13，6：	1
20	Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers显示文摘	Bronte V Kasic T Gri G	2005	J Exp Med2005，201，8：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示